Nasdaq Crsp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq crsp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Crsp Today - Breaking & Trending Today

JFG Wealth Management LLC Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP)

JFG Wealth Management LLC bought a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,510 shares of the company’s stock, valued at approximately $220,000. Several other hedge […] ....

Samarth Kulkarni , Raju Prasad , Exchange Commission , Tradewinds Capital Management , Bourgeon Capital Management , Financial Management Inc , Blue Trust Inc , Wells Fargo Company , Morgan Stanley , Jfg Wealth Management , Wolfe Research , Free Report , Capital Management , Chardan Capital , Get Free Report , Visit Holdingschannel , Crispr Therapeutics , Nasdaq Crsp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Capital Investment Advisory Services LLC Increases Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)

Capital Investment Advisory Services LLC lifted its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,636 shares of the company’s stock after buying an additional 855 shares during […] ....

Samarth Kulkarni , Jamesr Kasinger , Bourgeon Capital Management , Wolfe Research , Needham Company , Securities Exchange Commission , Tradewinds Capital Management , Blue Trust Inc , Capital Investment Advisory Services , Financial Management Inc , Wells Fargo Company , Free Report , Investment Advisory Services , Capital Management , Get Free Report , Exchange Commission , General Counsel James , Crispr Therapeutics , Nasdaq Crsp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.2%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 0.2% during mid-day trading on Monday . The stock traded as low as $54.37 and last traded at $54.95. Approximately 262,647 shares traded hands during trading, a decline of 86% from the average daily volume of 1,824,210 shares. The stock had previously closed at […] ....

Jamesr Kasinger , Samarth Kulkarni , Investment Management , Royal Bank , Morgan Stanley , Jump Financial , Invesco Ltd , Wells Fargo Company , Capital Advisors Inc , Therapeutics Company Profile , Securities Exchange Commission , Get Free Report , Exchange Commission , General Counsel James , Crispr Therapeutics , Nasdaq Crsp ,

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.2%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0.2% during mid-day trading on Monday . The stock traded as low as $54.37 and last traded at $54.95. 262,647 shares were traded during trading, a decline of 86% from the average session volume of 1,824,210 shares. The stock had previously closed at $55.05. Wall Street […] ....

Samarth Kulkarni , Raju Prasad , Norges Bank , Wolfe Research , Vestmark Advisory Solutions Inc , Morgan Stanley , Investment Management , Baillie Gifford Co , Westfield Capital Management Co , Securities Exchange Commission , Get Free Report , Chardan Capital , Exchange Commission , Capital Management , Vestmark Advisory Solutions , Crispr Therapeutics , Nasdaq Crsp ,

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 1.8% on Insider Selling

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price fell 1.8% during mid-day trading on Wednesday after an insider sold shares in the company. The company traded as low as $56.75 and last traded at $56.90. 296,744 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 1,831,639 […] ....

Nova Scotia , Samarth Kulkarni , Raju Prasad , T Rowe Price Investment Management Inc , Capital International Investors , Royal Bank , Investment Management , Blackrock Inc , Pricet Rowe Associates Inc , Wells Fargo Company , Get Free Report , Chardan Capital , International Investors , Rowe Price Investment Management , Crispr Therapeutics , Nasdaq Crsp ,